NDC 0002-8233-01 - Insulin Lispro Protamine and Insulin Lispro Injectable Suspension Mix75/25 KwikPen
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0002-8233
- Requested NDC
- 0002-8233-01
- Package NDCs from labels
- 0002-8233-01, 0002-8233-05
- Manufacturer
- Eli Lilly and Company
- Effective date
- 2024-08-06
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Insulin lispro - Eli Lilly and Company | Eli Lilly and Company | 2024-08-06 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0002-8233-01 | Insulin Lispro Protamine and Insulin Lispro Injectable Suspension Mix75/25 KwikPen | 3 mL in 1 SYRINGE | INJECTION, SUSPENSION | 3 | 11 | |
| 0002-8233-05 | Insulin Lispro Protamine and Insulin Lispro Injectable Suspension Mix75/25 KwikPen | 5 in 1 CARTON | INJECTION, SUSPENSION | 5 | 11 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 0002-8233 | INSULIN LISPRO PROTAMINE AND INSULIN LISPRO INJECTABLE SUSPENSION MIX75/25 KWIKPEN (INSULIN LISPRO) INJECTION, SUSPENSION [ELI LILLY AND COMPANY] | 11 | Current NDC, Legacy NDC, 2 package rows | 20240809_e49f701d-c19f-4cb2-b63f-01a917b33abc.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0002-8233-01 | ML - Milliliter | 0002-8233 | 4a2fed7b-72a3-4e42-8e76-f48c3c1a3e7b | 1 | 2020-04-20 |
| 0002-8233-05 | ML - Milliliter | 0002-8233 | d0f86a34-6362-454b-9fdf-b12594c4825c | 1 | 2020-04-20 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| TOTAL DEFENSE REPAIR BROAD SPECTRUM SPF 34 Sunscreen (Tinted) | OCTINOXATE, OCTISALATE, TITANIUM DIOXIDE AND ZINC OXIDE | Allergan, Inc. | 6a996e03-907f-4e6a-b232-0892b86956b0 | 2015-08-21 | Warnings | SOI2LOH54Z |
| Renewal Firming Day Broad Spectrum SPF 30 | TITANIUM DIOXIDE, ZINC OXIDE | BURT'S BEES, INC. | 18ceb5d8-4b76-6a54-e054-00144ff88e88 | 2015-06-18 | Warnings | SOI2LOH54Z |
| TiZO2 | TITANIUM DIOXIDE, ZINC OXIDE | Fallien Cosmeceuticals, LTD. | 30468afc-9616-4765-b046-12e97a0a7827 | 2010-12-20 | Warnings | SOI2LOH54Z |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.